The utility of p16(INK4a) and Ki-67 to identify high-grade squamous intraepithelial lesion in adolescents and young women

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
MEDKNOW PUBLICATIONS & MEDIA PVT LTD
Autores
CAVALCANTE, Diane M.
POMPEU, Margarida M. L.
GIRALDO, Paulo C.
ELEUTERIO JR., Jose
Citação
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, v.55, n.3, p.339-342, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The repair of the immature squamous epithelium following HPV infection may mimic HSIL in adolescent women. Aim: to study the utility of p16(INK4a) and Ki-67 in diagnosis of cervical squamous lesions in adolescents and young adults. Materials and Methods: In a cross-sectional study, the evaluation of p16(INK4a) and Ki-67 immunohistochemistry was performed on 72 cervical biopsies of adolescents and young adults women diagnosed as negative for malignancy and intraepithelial lesion (NML) (n = 18) or positive for low grade (LSIL) (n = 31) and high grade (HSIL) (n = 23) squamous intraepithelial lesions in two references services in Fortaleza-Brazil. Data was evaluated using Fisher's test and Kappa index. Results: p16(INK4a) was positive in 81% of HSIL, 19% of LSIL and in no NML (P < 0.0001). Ki-67 was positive in 74%, 32% and 5.5% of HSIL, LSIL and NML, respectively. p16(INK4a) and Ki-67 in the diagnosis of HSIL showed high sensitivity and negative predictive value. Kappa index was very good for p16(INK4a) (k = 0.72). Conclusions: In adolescents and young adults p16(INK4a) alone or with Ki-67 represents important tool to reduce mistaken diagnosis of HSIL and to avoid overtreatment.
Palavras-chave
Adolescent, Ki-67, p16, squamous intraepithelial lesions, young adult
Referências
  1. Agoff SN, 2003, MODERN PATHOL, V16, P665, DOI 10.1097/01.MP.0000077518.78046.0C
  2. Branca N, 2004, INT J GYNECOL PATHOL, V23, P354
  3. Duggan MA, 2006, HUM PATHOL, V37, P1473, DOI 10.1016/j.humpath.2006.05.013
  4. Eleuterio J, 2007, ACTA OBSTET GYN SCAN, V86, P94, DOI 10.1080/00016340601089727
  5. Fuchs K, 2007, J PEDIATR ADOL GYNEC, V20, P269, DOI 10.1016/j.jpag.2007.04.012
  6. Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4
  7. Gupta R, 2010, INDIAN J PATHOL MICR, V53, P7, DOI 10.4103/0377-4929.59174
  8. Horn LC, 2008, AM J SURG PATHOL, V32, P502, DOI 10.1097/PAS.0b013e31815ac420
  9. Hu LL, 2005, MODERN PATHOL, V18, P267, DOI 10.1038/modpathol.3800290
  10. Iaconis L, 2007, ARCH PATHOL LAB MED, V131, P1343
  11. Kalof AN, 2005, AM J SURG PATHOL, V29, P674, DOI 10.1097/01.pas.0000155164.78785.c2
  12. Keating JT, 2001, AM J SURG PATHOL, V25, P884, DOI 10.1097/00000478-200107000-00006
  13. Kjaer SK, 2001, CANCER EPIDEM BIOMAR, V10, P101
  14. Klaes R, 2002, AM J SURG PATHOL, V26, P1389, DOI 10.1097/00000478-200211000-00001
  15. Kurman RJ, 1994, BLAUSTEINS PATHOLOGY
  16. Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995
  17. Myers ER, 2000, AM J EPIDEMIOL, V151, P1158
  18. Nam Eun Ji, 2008, J Gynecol Oncol, V19, P162, DOI 10.3802/jgo.2008.19.3.162
  19. Pinto AP, 2008, MODERN PATHOL, V21, P1067, DOI 10.1038/modpathol.2008.101
  20. Shi J, 2007, HUM PATHOL, V38, P1335, DOI 10.1016/j.humpath.2007.01.025
  21. Spitzer M, 2007, OBG MANAGEMENT S, P5
  22. Srivastava S, 2010, INDIAN J PATHOL MICR, V53, P518, DOI 10.4103/0377-4929.68301
  23. Tortolero-Luna G, 1999, HEMATOL ONCOL CLIN N, V13, P245, DOI 10.1016/S0889-8588(05)70163-5
  24. Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005
  25. Volgareva G, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-58
  26. Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x